Bindarit retards renal disease and prolongs survival in murine lupus autoimmune disease
Authors:
- Daniela CornaDCDaniela Corna
- Giuditta BenedettiGBGiuditta Benedetti
- Marina MorigiMMMarina Morigi
- Roberta DonadelliRDRoberta Donadelli
- Angelo GuglielmottiAGAngelo Guglielmotti
- Mario PinzaMPMario Pinza
- Tullio BertaniTBTullio Bertani
- Giuseppe RemuzziGiuseppe Remuzzi
- 1 March 1998
- journal article
- Published by Elsevier in Kidney International
- Vol. 53 (3) , 726-734
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritisKidney International, 1996
- Apoptosis, nucleosomes, and nephritis in systemic lupus erythematosusKidney International, 1995
- Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes.Journal of Clinical Investigation, 1995
- Human monocyte chemoattractant protein-1 (MCP-1)Immunology Today, 1990
- Lupus nephritis: Correlation of interstitial cells with glomerular functionKidney International, 1990
- Monoclonal antibody identification of infiltrating mononuclear leukocytes in lupus nephritisKidney International, 1986
- Therapy of Lupus NephritisNew England Journal of Medicine, 1986
- Etiopathogenesis of Murine SLE1Immunological Reviews, 1981
- Therapeutic studies in NZB/W MICEArthritis & Rheumatism, 1975
- Therapeutic studies in NZB/W mice. I. Synergy of azathioprine, cyclophosphamide and methylprednisolone in combinationArthritis & Rheumatism, 1972